Future of reperfusion therapy for acute myocardial infarction.
White
H D
HD
Cardiology Department, Green Lane Hospital, Auckland, New Zealand.
D000328:Adult; D015906:Angioplasty, Balloon, Coronary / Q000639:trends*; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D005544:Forecasting; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000628:therapy*; D015425:Myocardial Reperfusion / Q000639:trends*; D015607:Stents / Q000639:trends; D015996:Survival Rate; D000077785:Tenecteplase; D015912:Thrombolytic Therapy / Q000639:trends*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage* / Q000009:adverse effects
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator; D000077785:Tenecteplase